Table 2. Clinical course of disease.
| All patients | Asymptomatic patients | Mild (symptomatic outpatients) | Moderate (hospitalized) | Critical (ventilation) | Deceased | |
|---|---|---|---|---|---|---|
| n (%) | 897 (100) | 54 (6.0) | 713 (79.5) | 97 (10.8) | 16 (1.8) | 17 (1.9) |
| Symptoms# | ||||||
| n (%) | ||||||
| 1. Fever | 481 (53.6) | Asymptomatic | 374 (52.5) | 82 (84.5) | 13 (81.3) | 12 (70.6) |
| 2. Cough | 552 (61.5) | 457 (64.1) | 72 (74.2) | 9 (56.3) | 14 (82.4) | |
| 3. Sputum | 79 (8.8) | 75 (10.5) | 10 (10.3) | 3 (18.8) | 1 (5.9) | |
| 4. Sore throat | 306 (32.1) | 269 (37.7) | 32 (33.0) | 5 (31.3) | 1 (5.9) | |
| 5. Dyspnea | 181 (20.1) | 113 (15.8) | 50 (51.5) | 10 (62.5) | 8 (47.1) | |
| 6. Muscle pain | 279 (31.1) | 242 (33.9) | 27 (27.8) | 8 (50.0) | 2 (11.8) | |
| 7. Limb pain | 432 (48.1) | 373 (52.3) | 47 (48.5) | 10 (62.5) | 2 (11.8) | |
| 8. Fatigue | 586 (65.3) | 524 (73.5) | 64 (66.0) | 9 (56.3) | 11 (64.7) | |
| 9. Headache | 513 (57.2) | 450 (63.1) | 53 (54.6) | 8 (50.0) | 2 (11.8) | |
| 10. Runny nose | 270 (30.1) | 253 (35.5) | 15 (15.5) | 2 (12.5) | 0 (0.0) | |
| 11. Chest pain | 154 (17.1) | 135 (18.9) | 15 (15.5) | 2 (12.5) | 2 (11.8) | |
| 12. Diarrhea | 212 (23.6) | 173 (24.3) | 29 (29.9) | 5 (31.3) | 5 (29.4) | |
| 13. Nausea | 96 (10.7) | 77 (10.8) | 14 (14.4) | 3 (18.8) | 2 (11.8) | |
| 14. Change in taste | 537 (59.8) | 480 (67.3) | 50 (51.5) | 6 (37.5) | 1 (5.9) | |
| 15. Other | 304 (33.9) | 259 (36.3) | 20 (20.6) | 4 (25.0) | 2 (11.8) | |
| Comorbidities n (%) | ||||||
| Cardiac disease | 197 (22.0) | 14 (25.9) | 119 (16.7) | 39 (40.2) | 12 (75.0) | 13 (76.5) |
| Hypertension | 152 (17.0) | 9 (16.7) | 98 (13.7) | 29 (29.9) | 6 (37.5) | 10 (58.8) |
| CHD | 19 (2.1) | 2 (3.7) | 7 (1.0) | 2 (2.1) | 2 (12.5) | 6 (35.3) |
| Lung disease | 124 (13.8) | 8 (14.8) | 87 (12.2) | 22 (22.7) | 4 (25.0) | 3 (17.7) |
| Kidney disease | 24 (2.7) | 3 (5.6) | 13 (1.8) | 4 (4.1) | 2 (12.5) | 2 (11.8) |
| Liver disease | 13 (1.5) | 1 (1.9) | 6 (0.8) | 5 (5.2) | 1 (6.3) | 0 (0.0) |
| Diabetes mellitus | 44 (4.9) | 4 (7.4) | 25 (3.5) | 9 (9.3) | 4 (25.0) | 2 (11.8) |
| Autoimmune disorder | 52 (5.8) | 3 (5.6) | 40 (5.6) | 8 (8.3) | 1 (6.3) | 0 (0.0) |
| HIV positive | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
| Malignancy | 49 (5.5) | 5 (9.3) | 26 (3.7) | 14 (14.4) | 1 (6.3) | 3 (17.7) |
| Other | 168 (19) | 8 (14.8) | 129 (18.1) | 27 (27.8) | 5 (31.3) | 9 (52.9) |
| Medication n (%) | ||||||
| Any | 346 (38.6) | 20 (37.0) | 271 (38.0) | 40 (41.2) | 10 (62.5) | 5 (29.4) |
| NSAR | 71 (7.9) | 7 (13.0) | 51 (7.2) | 8 (8.3) | 2 (12.5) | 3 (17.7) |
| ACEI | 52 (5.8) | 4 (7.4) | 30 (4.2) | 12 (12.4) | 5 (31.3) | 1 (5.9) |
| AT1-Inhibitors | 82 (9.1) | 6 (11.1) | 60 (8.4) | 13 (13.4) | 3 (18.8) | 0 (0.0) |
| Immunosuppressants | 42 (4.7) | 1 (1.9) | 32 (4.5) | 9 (9.3) | 0 (0.0) | 0 (0.0) |
| Chemotherapy | 1 (0.1) | 0 (0.0) | 0 (0.0) | 1 (1.0) | 0 (0.0) | 0 (0.0) |
| Smoking n (%) | ||||||
| Never | 533 (59.4) | 40 (74.1) | 442 (62.3) | 43 (44.3) | 5 (31.3) | 3 (17.7) |
| Former | 246 (27.4) | 8 (14.8) | 198 (27.8) | 32 (33.0) | 6 (37.5) | 2 (11.8) |
| Current | 82 (9.1) | 5 (9.3) | 71 (10.0) | 5 (5.2) | 0 (0.0) | 1 (5.9) |
| Missing | 36 (4.0) | 1 (1.9) | 2 (0.3) | 17 (17.5) | 5 (31.3) | 11 (64.7) |
| Days from illness onset to diagnosis Mean (SD) | 6 (4) | x | 6 (4) | 6 (4) | 8 (2) | 7 (4) |
| Days from illness onset to recovery Mean (SD) | 14 (8) | x | 14 (7) | 19 (9) | 19 (8) | x |
Clinical characteristics and history of 897 participants with coronavirus disease 19 stratified by level of severity. Data are either numbers (percentages) or means (standard deviations) as indicated in the table. Given symptoms are pooled symptoms comprising of initial and developed symptoms. See S2 Table for further details.